PubMed Health⌕ Search

PubMed · 9914765

[Psychoanalysis beyond Freud].

Abstract

Since Sigmund Freud (1856-1939) formulated his first psychoanalytic theories about 100 years ago, there has been a rapid development in psychoanalytic theory and therapy. In this paper, central concepts in the four psychoanalytic "psychologies"--drive/ego psychology, object relations theory, self psychology and interpersonal psychoanalysis--are presented. Basic concepts in psychoanalysis have been under a continuous critical review, and psychoanalytic theories remain versatile. The unconscious and the exploration of subjective experience are central common themes. The role of the psychoanalyst has changed from expert to explorer, working together with the patient. At the same time, the analyst has become more active in the therapy room. The analyst's contribution to what is happening between the analyst and the patient has been increasingly emphasized. The development in psychoanalysis has parallelled both developments in the theory of knowledge as well as the change in cultural trends. Creating meaning is central to the psychoanalytic process, but there are divergent views as to how this happens: by articulating meaning, by uncovering meaning, by constructing or deconstructing meaning. The narrative tradition in which the central point is to tell stories about oneself, is discussed more thoroughly in the paper. The authors challenge the view that psychoanalysis is the work of Freud only.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Råbu, K Hytten. 1998-12-10. [Psychoanalysis beyond Freud].. https://pubmed.ncbi.nlm.nih.gov/9914765/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Transitional cell carcinoma in patients with spinal cord injury: a high risk malignancy?

OBJECTIVES: To study bladder cancer incidence in patients with spinal cord injury (SCI) in Germany, Switzerland, and Austria. SCI is associated with neurogenic bladder dysfunction. These patients are at an increased risk of developing bladder malignancies. METHODS: A questionnaire was mailed to all SCI centers in these countries. The number of patients with SCI treated between 1995 and 1999, and the data of all patients with SCI with bladder cancer were recorded. RESULTS: The charts of 43,561 patients were reviewed. Of these, 48 patients (0.11%) developed bladder cancer. The data of 8 female and 29 male patients were fully available. The mean age was 53.3 years. Bladder management was reflex voiding in 18 patients, intermittent catheterization in 12 patients, and an indwelling catheter in 7 patients. Twelve patients were smokers. The mean time between SCI and the first bladder cancer diagnosis was 22.6 years. Thirty-two percent had superficial cancers, 8% had carcinoma in situ, and 60% presented with muscle-infiltrating tumors; 81% had urothelial cancer and 19% squamous cell cancer. Thirteen patients rarely had urinary tract infections (UTIs), 9 had more than 10 UTIs annually, and 15 had chronic UTIs. CONCLUSIONS: The bladder cancer incidence in patients with SCI and in the general population is comparable. More than 60% of the patients with SCI, however, initially presented with muscle-infiltrating bladder cancer. Indwelling catheters and chronic UTIs were common in patients with bladder cancer. Immunologic pathologic mechanisms and a prolonged exposure to carcinogens may be involved in bladder cancer carcinogenesis in patients with SCI.

Austria↗